Dermatology News and Research

Latest Dermatology News and Research

Data on PV-10 combination therapy presented at AACR Annual Meeting

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, presented data on PV-10 combination therapy today at the American Association for Cancer Research Annual Meeting in Washington, DC.

11 Apr 2013

Finding avoids needless exposure to potentially toxic treatment

Systemic sclerosis, also known as scleroderma, is a rare autoimmune connective tissue disorder that's difficult to treat. However, thanks to new research at Northwestern University Feinberg School of Medicine and Dartmouth's Geisel School of Medicine, doctors may be able to treat some patients more effectively.

11 Apr 2013

Dermatologist shares manicure and pedicure tips for beautiful nails

Having beautiful nails is less a matter of luck and more a matter of caring for them correctly. Fortunately, there are simple steps people can take to properly care for their nails.

10 Apr 2013

UT professor earns INNOVATOR Award for Cancer Prevention Research at AACR meeting 2013

A proposal to examine the cellular journey from normal skin, to precancerous lesion to skin cancer earned Kenneth Tsai, M.D., Ph.D., the Sixth Annual Landon Foundation-AACR INNOVATOR Award for Cancer Prevention Research at the AACR Annual Meeting 2013 in Washington, D.C., April 6-10.

9 Apr 2013

Patients with psoriasis carry increased risk of developing severe co-morbid conditions

The International Federation of Psoriasis Associations, IFPA, commends the World Health Organization for raising awareness of the risks associated with high blood pressure and calls for healthcare professionals to regularly scan for the condition in patients with psoriasis.

9 Apr 2013

Dermatology researcher secures federal grant to explore psoriasis

A dermatology researcher at Case Western Reserve University School of Medicine has secured a five-year, $1.9 million federal grant to explore whether a specific molecule may play a pivotal role in the development and progression of psoriasis.

5 Apr 2013

UAB School of Nursing offers health care services in rural communities

"If individuals, families, and communities don't have access, then they don't have the opportunity for a better life," asserts University of Alabama at Birmingham School of Nursing Dean Doreen C. Harper, PhD, RN, FAAN.

3 Apr 2013

New Jersey bans minors under age of 17 years old from using indoor tanning salons

New Jersey sent a strong message to young people that indoor tanning salons can be dangerous to their health. New Jersey has passed a law that bans minors under the age of 17 years old from using indoor tanning devices.

3 Apr 2013

Living cells and cell fragments move in response to electric fields, scientists find

Like tiny crawling compass needles, whole living cells and cell fragments orient and move in response to electric fields - but in opposite directions, scientists at the University of California, Davis, have found. Their results, published April 8 in the journal Current Biology, could ultimately lead to new ways to heal wounds and deliver stem cell therapies.

30 Mar 2013

Radiology trainees face earning challenges

For years, medical students who chose a residency in radiology were said to be on the ROAD to happiness. The acronym highlighted the specialties - radiology, ophthalmology, anesthesiology and dermatology - said to promise the best lifestyle for doctors, including the most money for the least grueling work. Not anymore.

30 Mar 2013

First Edition: March 28, 2013

Today's headlines include various stories about the health law's implementation at both the federal and state level.

28 Mar 2013

arGEN-X advances ARGX-112 into formal preclinical development

arGEN-X, a clinical stage biopharmaceutical company specialized in the discovery and development of highly differentiated human monoclonal antibody therapeutics, announces that it has progressed ARGX-112, its fourth therapeutic candidate, into formal preclinical development.

25 Mar 2013

R-Tech Ueno enrolls retinitis pigmentosa patients in Phase 3 clinical study of UF-021 ophthalmic solution

R-Tech Ueno is pleased to announce the start of the patient enrollment of a Phase 3 clinical study with Unoprostone (development code UF-021) ophthalmic solution that are being developed in our company for the treatment of retinitis pigmentosa.

18 Mar 2013

Anti-cancer drug conjugates: an interview with Dr Andreas Menrad, CSO Ablynx and Dr Chris Martin, CEO Spirogen

Antibodies and in the case of Ablynx, Nanobodies, can be raised and selected to bind with high affinity selectively to cancer cells in a tumour. Cancer cells are exquisitely sensitive to certain toxins such as the PBDs produced by Spirogen.

12 Mar 2013

Combining mitochondrial inhibitors could improve efficacy of BRAF inhibitors in melanoma

A multi-institutional study has revealed that BRAF-positive metastatic malignant melanomas develop resistance to treatment with drugs targeting the BRAF/MEK growth pathway through a major change in metabolism.

11 Mar 2013

Halometasone and fusidic acid optimal for infected eczema

Results from a randomized, open-label phase III trial suggest that a combination cream of halometasone and fusidic acid reduces symptoms of eczema to a similar degree to a betamethasone and neomycin sulphate cream, but is more effective at treating infected lesions.

8 Mar 2013